MECP2 and cancer: Future work may identify more factors involved in this SIRT1-MeCP2 regulatory network, and through such work, our understanding of the key molecular relationships in cancer may lead to deeper understanding of the mechanism of action of epigenetic therapies and KDAC inhibitors.